DermTech Financial Statements (DMTK)
|
|
|
|
Report date
|
|
|
11.03.2020 |
05.03.2021 |
10.03.2022 |
02.03.2023 |
29.02.2024 |
|
15.05.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
3.36 |
5.89 |
11.8 |
14.5 |
15.3 |
|
15.7 |
|
Operating Income, bln rub |
|
|
-17.6 |
-35.3 |
-77.4 |
-118.2 |
-103.7 |
|
-90.9 |
|
EBITDA, bln rub |
? |
|
-18.0 |
-35.3 |
-76.3 |
-118.3 |
-97.9 |
|
-85.3 |
|
Net profit, bln rub |
? |
|
-21.9 |
-34.7 |
-77.0 |
-113.7 |
-100.9 |
|
-89.6 |
|
|
OCF, bln rub |
? |
|
-17.8 |
-28.7 |
-62.1 |
-95.3 |
-77.0 |
|
-72.1 |
|
CAPEX, bln rub |
? |
|
0.210 |
1.83 |
2.72 |
3.31 |
0.902 |
|
0.471 |
|
FCF, bln rub |
? |
|
-18.0 |
-30.5 |
-64.8 |
-98.6 |
-77.9 |
|
-72.2 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
17.7 |
35.2 |
78.7 |
118.8 |
104.0 |
|
92.2 |
|
Cost of production, bln rub |
|
|
3.30 |
5.98 |
10.6 |
13.9 |
15.0 |
|
14.3 |
|
R&D, bln rub |
|
|
2.50 |
5.29 |
16.3 |
24.1 |
15.2 |
|
14.1 |
|
Interest expenses, bln rub |
|
|
2.66 |
0.040 |
0.000 |
1.34 |
0.000 |
|
0.775 |
|
|
Assets, bln rub |
|
|
18.2 |
69.8 |
248.3 |
202.1 |
121.9 |
|
103.0 |
|
Net Assets, bln rub |
? |
|
12.5 |
63.5 |
229.7 |
132.4 |
57.2 |
|
40.0 |
|
Debt, bln rub |
|
|
0.000 |
0.335 |
7.86 |
55.8 |
54.4 |
|
53.7 |
|
Cash, bln rub |
|
|
15.4 |
63.8 |
225.3 |
126.2 |
55.9 |
|
39.0 |
|
Net debt, bln rub |
|
|
-15.4 |
-63.4 |
-217.5 |
-70.3 |
-1.47 |
|
14.7 |
|
|
Ordinary share price, rub |
|
|
12.4 |
32.4 |
15.8 |
1.77 |
1.75 |
|
1.55 |
|
Number of ordinary shares, mln |
|
|
7.01 |
17.0 |
28.9 |
30.0 |
32.6 |
|
34.7 |
|
|
Market cap, bln rub |
|
|
87 |
551 |
456 |
53 |
57 |
|
54 |
|
EV, bln rub |
? |
|
71 |
487 |
239 |
-17 |
56 |
|
68 |
|
Book value, bln rub |
|
|
12 |
63 |
230 |
132 |
57 |
|
40 |
|
|
EPS, rub |
? |
|
-3.13 |
-2.05 |
-2.66 |
-3.79 |
-3.09 |
|
-2.58 |
|
FCF/share, rub |
|
|
-2.57 |
-1.80 |
-2.24 |
-3.28 |
-2.39 |
|
-2.08 |
|
BV/share, rub |
|
|
1.78 |
3.74 |
7.95 |
4.41 |
1.75 |
|
1.15 |
|
|
EBITDA margin, % |
? |
|
-533.9% |
-599.6% |
-644.6% |
-814.9% |
-640.0% |
|
-544.8% |
|
Net margin, % |
? |
|
-651.1% |
-590.0% |
-650.2% |
-783.3% |
-659.6% |
|
-572.2% |
|
FCF yield, % |
? |
|
-20.7% |
-5.54% |
-14.2% |
-185.4% |
-136.3% |
|
-134.2% |
|
ROE, % |
? |
|
-175.4% |
-54.7% |
-33.5% |
-85.9% |
-176.5% |
|
-224.1% |
|
ROA, % |
? |
|
-120.3% |
-49.8% |
-31.0% |
-56.3% |
-82.7% |
|
-87.0% |
|
|
P/E |
? |
|
-3.97 |
-15.9 |
-5.93 |
-0.47 |
-0.57 |
|
-0.60 |
|
P/FCF |
|
|
-4.83 |
-18.0 |
-7.04 |
-0.54 |
-0.73 |
|
-0.74 |
|
P/S |
? |
|
25.8 |
93.6 |
38.6 |
3.66 |
3.73 |
|
3.43 |
|
P/BV |
? |
|
6.96 |
8.68 |
1.99 |
0.40 |
1.00 |
|
1.35 |
|
EV/EBITDA |
? |
|
-3.98 |
-13.8 |
-3.13 |
0.15 |
-0.57 |
|
-0.80 |
|
Debt/EBITDA |
|
|
0.86 |
1.80 |
2.85 |
0.59 |
0.02 |
|
-0.17 |
|
|
R&D/CAPEX, % |
|
|
1 189% |
288.6% |
597.8% |
727.7% |
1 689% |
|
2 993% |
|
|
CAPEX/Revenue, % |
|
|
6.24% |
31.2% |
23.0% |
22.8% |
5.90% |
|
3.01% |
|
| DermTech shareholders |
